Sorrento Therapeutics, Inc.

SRNE

Statistics

$5.75Share Price
$442 MMarket Cap
15.2%EBIT / EV
N/AFCF / EV
25.6%ROIC
N/ACash ROIC
276.3%3yr Avg Revenue Growth
0.54Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 15.2% ranks as Very High.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
check mark The Return on Invested Capital Value of 25.6% ranks as Very High.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 276.3% ranks as Very High.
x mark Near-term Financial Health appears to be Worrisome. The Current Ratio is 0.54.

Company Description

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!